Skip to main content
. 2016 Jan 31;7(11):12305–12317. doi: 10.18632/oncotarget.7104

Table 1. Potential strategies for CRISPR/Cas9 interventions targeting cellular genes in cancer.

Gene Type Family Example Gene Function Approach Gene Reference
Oncogene Receptor tyrosine kinase ErbB Tyrosine kinase Disrupt or mutate 48, 58
Nonreceptor src, abl, fps, yes, Tyrosine kinase Disrupt or mutate 49
G proteins ras Molecular Switch Disrupt or mutate 50
Signaling kinase raf Serine/threonine kinase Disrupt or mutate 51
Transcription regulator myc Transcription factor Disrupt or mutate 52
Tumor Suppressor Pocket protein pRb Cell cycle regulator Repair 78-80
Gene Regulation p53 Transcription Repair 81
Signal regulation PTEN Protein phosphatase Repair 82
DNA repair BRCA1/2 DNA repair Repair 83, 84
DNA damage checkpoint ATM Serine/threonine kinase Repair 85
Epigenetic Conrol loci DNMTs DNMT1 DNA methyltransferase Repair 101
Histone modification EZH2/ Histone methylase demethylase Repair 103, 104
Chemo-resistance Efflux pumps MDR-1 MRP ABC transporter Repair 107, 108
Drug metabolism GST-p GSH conjugation Repair 111
Cytokine P450 Inactivation Repair 112
UGT1A1 Gluconylation Repair 113